良好预后患者单次冻融胚胎移植中,基于非整倍体植入前遗传学检测与形态学选择标准的比较:一项多中心随机临床试验
这项多中心随机对照试验将661名25-40岁、至少有两个可活检囊胚的IVF女性随机分为基于NGS的PGT-A选择组(n=330)与单纯形态学选择组(n=331),行单次冻融胚胎移植。每移植周期持续妊娠率两组无显著差异(50% [137/274] vs 46% [143/313]),意向性分析(ITT)亦无显著差异(41.8% [138/330] vs 43.5% [144/331])。事后分析显示35-40岁女性每移植周期持续妊娠率显著升高(51% [62/122] vs 37% [54/145]),但ITT分析未达显著。
要点
- 全体人群中PGT-A未改善每移植周期或ITT的持续妊娠率。
- 35-40岁女性事后分析每移植周期持续妊娠率PGT-A组51% vs 形态学组37%。
- 上述35-40岁亚组获益在ITT分析中未达统计学显著。
核心结论
- PGT-A未改善所有女性整体的妊娠结局,无论按每移植周期还是按ITT分析。
- 在35-40岁且至少有两个可活检胚胎的女性亚组中,PGT-A使每移植周期持续妊娠率显著升高,但按ITT分析未达显著。
研究设计与样本
- 随机对照试验,纳入25-40岁、至少有两个可活检囊胚的IVF女性。
- 共661名女性(平均年龄33.7 ± 3.6岁)随机分为PGT-A组(n=330)与单纯形态学选择组(n=331),行单次冻融胚胎移植。
- 主要结局为每移植周期妊娠20周的持续妊娠率。
主要发现
- 每移植周期持续妊娠率PGT-A组50%(137/274) vs 形态学组46%(143/313),无显著差异。
- 按ITT分析持续妊娠率PGT-A组41.8%(138/330) vs 形态学组43.5%(144/331),无显著差异。
- 事后分析35-40岁女性每移植周期持续妊娠率PGT-A组51%(62/122) vs 形态学组37%(54/145),显著升高。
- 35-40岁女性按ITT分析持续妊娠率未达统计学显著。
局限性
- 35-40岁女性的持续妊娠率获益来自事后分析,按ITT分析未达统计学显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the benefit of next-generation sequencing (NGS)-based preimplantation genetic testing for aneuploidy (PGT-A) for embryo selection in frozen-thawed embryo transfer. DESIGN: Randomized controlled trial. SETTING: Not applicable. PATIENT(S): Women aged 25-40 years undergoing IVF with at least two blastocysts that could be biopsied. INTERVENTION(S): Randomization for single frozen-thawed embryo transfer with embryo selection based on PGT-A euploid status versus morphology. MAIN OUTCOME MEASURE(S): Ongoing pregnancy rate (OPR) at 20 weeks' gestation per embryo transfer. RESULT(S): A total of 661 women (average age 33.7 ± 3.6 years) were randomized to PGT-A (n = 330) or morphology alone (n = 331). The OPR was equivalent between the two arms, with no significant difference per embryo transfer (50% [137/274] vs. 46% [143/313]) or per intention to treat (ITT) at randomization (41.8% [138/330] vs. 43.5% [144/331]). Post hoc analysis of women aged 35-40 years showed a significant increase in OPR per embryo transfer (51% [62/122] vs. 37% [54/145]) but not per ITT. CONCLUSION(S): PGT-A did not improve overall pregnancy outcomes in all women, as analyzed per embryo transfer or per ITT. There was a significant increase in OPR per embryo transfer with the use of PGT-A in the subgroup of women aged 35-40 years who had two or more embryos that could be biopsied, but this was not significant when analyzed by ITT. CLINICAL TRIAL REGISTRATION NUMBER: NCT02268786.
引用
- Munné S, Kaplan B, Frattarelli JL, et al. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertil Steril. 2019. PMID: 31551155. doi:10.1016/j.fertnstert.2019.07.1346
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。